Top

Published in:

28-10-2022 | Human Papillomavirus | Review Article

Gynaecological Oncology in India: Past, Present and Future

Authors: Rohini Kulkarni, Sudeep Gupta

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2022

Abstract

Gynaecological cancers contribute to a substantial portion of the global cancer burden. Traditionally, these cancers have been treated by generalists, including gynaecologists and surgeons. However, owing to increasing sophistication and challenges in their management, a new sub-speciality of Gynaecologic Oncology, dedicated to these women’s comprehensive care, has emerged in recent times. The emergence and evolution of this sub-speciality will facilitate a holistic approach to treating women suffering from gynaecological cancers, including tailored surgical techniques, fertility preservation, precision medicine, hormone modulators, targeted therapy and immunotherapy, which can be achieved within the framework of multidisciplinary management. Hence, we decided to write this synopsis to shed light on the evolution of this discipline in India and offer current and future perspectives.

World Health Organisation(WHO) The Global Cancer Observatory(GLOBOCAN). https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. Accessed 7 Aug 2022

du Bois A, Rochon J, Pfisterer J, Hoskins WJ (2009) Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 112(2):422–36. https://doi.org/10.1016/j.ygyno.2008.09.036CrossRef

Vernooij F, Heintz P, Witteveen E, van der Graaf Y (2007) The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 105(3):801–12. https://doi.org/10.1016/j.ygyno.2007.02.030CrossRef

Fung-Kee-Fung M, Kennedy EB, Biagi J et al (2015) The optimal organization of gynecologic oncology services: a systematic review. Curr Oncol 22(4):e282-93. https://doi.org/10.3747/co.22.2482CrossRef

Franasiak JM, Scott RT (2016) Demographics of cancer in the reproductive age female. In: Sabanegh, Jr E (ed) Cancer and fertility. Current clinical urology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-27711-0_2CrossRef

Averette HE, Wrennick A, Angioli R (2001) History of gynecologic oncology subspecialty. Surg Clin North Am 81(4):747–51. https://doi.org/10.1016/S0039-6109(05)70162-6CrossRef

Banerjee S, Mahantshetty U, Shrivastava S (2014) Brachytherapy in India — a long road ahead. J Contemp Brachytherapy 6(3):331–5. https://doi.org/10.5114/jcb.2014.45761CrossRef

Shrivastava S (2005) Brachytherapy — perspectives in evolution: take it with a bag of salt. J Cancer Res Ther 1(2):73–4. https://doi.org/10.4103/0973-1482.16704CrossRef

Munshi A, Ganesh T, Mohanti B (2019) Radiotherapy in India: history, current scenario and proposed solutions. Indian J Cancer 56(4):359–363. https://doi.org/10.4103/ijc.IJC_82_19CrossRef

10.

Sushruta, Bhishagratha KL (1963) An English Translation of the Sushrutha Samhita: Based on Original Sanskrit Text, 2nd edn. Chowkhamba Sanskrit, Varanasi

11.

Charaka, Kaviratna AC (1991) Charaka Samhita: Translated into English. Choukambha Sanskrit, Varanasi

12.

Mitra S (1959) Extraperitoneal lymphadenectomy and radical vaginal hysterectomy for cancer of the cervix (Mitra technique). Am J Obstet Gynecol 78(1):191–6. https://doi.org/10.1016/0002-9378(59)90661-1CrossRef

13.

Dixit V (2018) Unknown facets of “Not so well-known scientist” Dr. Y Subbarow: a great scientist, who did not receive the Nobel Prize. J Mar Med Soc 20(2):141. https://doi.org/10.4103/jmms.jmms_69_18CrossRef

14.

Maheshwari A, Kumar N, Mahantshetty U (2016) Gynecological cancers: a summary of published Indian data. South Asian J Cancer 05(03):112–20. https://doi.org/10.4103/2278-330X.187575CrossRef

15.

Shastri SS, Mittra I, Mishra GA et al (2014) Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. JNCI J Natl Cancer Ins 106(3):dju009. https://doi.org/10.1093/jnci/dju009CrossRef

16.

Sankaranarayanan R, Esmy PO, Rajkumar R et al (2007) Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370(9585):398–406. https://doi.org/10.1016/S0140-6736(07)61195-7CrossRef

17.

Sankaranarayanan R, Nene BM, Shastri SS et al (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360(14):1385–94. https://doi.org/10.1056/NEJMoa0808516CrossRef

18.

Sankaranarayanan R, Joshi S, Muwonge R et al (2018) Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study. Vaccine 36(32):4783–4791. https://doi.org/10.1016/j.vaccine.2018.02.087CrossRef

19.

Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D (2022) Secular trends in incidence and mortality of cervical cancer in India and its states, 1990–2019: data from the Global Burden of Disease 2019 Study. BMC Cancer 22(1):149. https://doi.org/10.1186/s12885-022-09232-wCrossRef

20.

Gupta S, Kerkar RA, Dikshit R, Badwe RA (2013) Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer 02(04):193–7. https://doi.org/10.4103/2278-330X.119887CrossRef

21.

Shrivastava S, Mahantshetty U, Engineer R et al (2018) Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix. JAMA Oncol 4(4):506–513. https://doi.org/10.1001/jamaoncol.2017.5179CrossRef

22.

Gupta S, Maheshwari A, Parab P et al (2018) Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIB squamous cervical cancer: a randomized controlled trial. J Clin Oncol 36(16):1548–1555. https://doi.org/10.1200/JCO.2017.75.9985CrossRef

23.

Chopra S, Gupta S, Kannan S et al (2021) Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol 39(33):3682–3692. https://doi.org/10.1200/JCO.20.02530CrossRef

24.

Mahantshetty U, Teni T, Naga P et al (2018) Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy — a prospective observational study. Gynecol Oncol 148(2):299–304. https://doi.org/10.1016/j.ygyno.2017.11.034CrossRef

25.

Bhatla N, Berek JS, Cuello Fredes M et al (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 145(1):129–135. https://doi.org/10.1002/ijgo.12749CrossRef

26.

Bhatla N, Singhal S, Dhamija E, Mathur S, Natarajan J, Maheshwari A (2021) Implications of the revised cervical cancer FIGO staging system. Indian J Med Res 154(2):273–283. https://doi.org/10.4103/ijmr.IJMR_4225_20CrossRef

27.

Kumar A, Chopra S, Gupta S (2021) Contribution of Tata Memorial Centre, India, to cervical cancer care: journey of two decades. Indian J Med Res 154(2):319–328. https://doi.org/10.4103/ijmr.IJMR_339_21CrossRef

28.

Chopra SJ, Mathew A, Maheshwari A et al (2018) National cancer grid of India consensus guidelines on the management of cervical cancer. J Glob Oncol 4:1–15. https://doi.org/10.1200/JGO.17.00152CrossRef

29.

Maheshwari A, Kumar N, Gupta S et al (2018) Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy. Indian J Cancer 55(1):50–54. https://doi.org/10.4103/ijc.IJC_468_17CrossRef

30.

Gupta S, Rajappa S, Advani S, Agarwal A, Aggarwal S, Goswami C, Palanki SD, Arya D, Patil S, Kodagali R (2021) Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study. JCO Glob Oncol. 7:849–861. https://doi.org/10.1200/GO.21.00051. PMID: 34101484; PMCID: PMC8457852

31.

Agarwal A, Baghmar S, Dodagoudar C et al (2021) PARP inhibitor in platinum-resistant ovarian cancer: single-center real-world experience. JCO Glob Oncol 7:506–511. https://doi.org/10.1200/GO.20.00269CrossRef

32.

Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2022) Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor in patients with newly diagnosed advanced epithelial ovarian cancer: individual patient data and trial-level meta-analysis. ESMO Open 7(5):100558. https://doi.org/10.1016/j.esmoop.2022.100558. Epub 2022 Aug 22. PMID: 36007449; PMCID: PMC9588903

33.

Dhillon PK, Yeole BB, Dikshit R, Kurkure AP, Bray F (2011) Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age–period–cohort analysis. Br J Cancer 105(5):723–30. https://doi.org/10.1038/bjc.2011.301CrossRef

34.

Indian society of peritoneal surface malignancies (2017) Available at: https://ispsm.org. Accessed 20 Sept 2022

35.

Somashekhar SP, Deo SVS, Sekhon R, Rao Thammineedi S et al (2022) Cytoreductive surgery plus HIPEC for advanced epithelial ovarian cancer: analysis from a multicentric national Indian HIPEC registry of 1,470 patients—an ISPSM collaborative study. J Clin Oncol 40(16):5525–5525CrossRef

36.

Clinical trials registry-India (2007) ICMR, National institute of medical statistics. Available at: http://ctri.nic.in/Clinicaltrials/advsearch.php. Accessed 7 Aug 2022

37.

Arnold M, Rutherford MJ, Bardot A et al (2019) Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol 20(11):1493–1505. https://doi.org/10.1016/S1470-2045(19)30456-5CrossRef

38.

NCI Term Browser (2022) National Cancer Institute. NCIthesaurus, Version 22.09ed. Available at: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C17830. Accessed 26 Sept 2022

39.

De Petrillo AD, Fung-Kee-Fung M, Allen H (2019) The evolution of the subspecialty of gynaecologic oncology in Canada and the GOC. J Obstet Gynaecol Can 41(Suppl 2):S231–S233. https://doi.org/10.1016/j.jogc.2019.09.005. PMID: 31785663

40.

Association of Gynaecologic Oncologist of India. Available at: http://www.agoi.org. Accessed 7 Aug 2022

41.

All India Super Speciality Courses, Allotment Process, Counselling. Directorate General of Health Services, Ministry of Health & Family Welfare Government of India, Medical Counseling Committee (MCC). Available at: https://intramcc.nic.in/mccss/seatmatrix.aspx. Accessed 7 Aug 2022

Title: Gynaecological Oncology in India: Past, Present and Future
Authors: Rohini Kulkarni
Sudeep Gupta
Publication date: 28-10-2022
Publisher: Springer India
Keywords: Human Papillomavirus
Ovarian Cancer
Cervical Cancer
Ovarian Cancer
Cervical Cancer
Published in: Indian Journal of Surgical Oncology / Issue Special Issue 1/2022
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-022-01668-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Gynaecological Oncology in India: Past, Present and Future

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2022

How Cancer Care Developed in India in 75 Years of Independence—Tamil Nadu Scenario

Development of Cancer Care in Northeast India

Development of Cancer Management and Care in Central India

Indian Association of Surgical Oncology (IASO)’s Contribution to Cancer Care in India

Strengthening Cancer Surveillance in India: Role of the National Cancer Registry Programme

My Journey of Becoming a Doctorpreneur—Transforming Dream into Reality